Rapid Antigen Assays for SARS-CoV-2: Promise and Peril

Though rapid antigen tests have historically problematic performance characteristics for the diagnosis of respiratory viral infections such as influenza, they have attained an unprecedented level of use in the context of the COVID-19 pandemic. Ease of use and scalability of rapid antigen tests has f...

Descripción completa

Detalles Bibliográficos
Autores principales: Truong, Thao T., Dien Bard, Jennifer, Butler-Wu, Susan M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8894733/
https://www.ncbi.nlm.nih.gov/pubmed/35636822
http://dx.doi.org/10.1016/j.cll.2022.03.001
_version_ 1784662749344694272
author Truong, Thao T.
Dien Bard, Jennifer
Butler-Wu, Susan M.
author_facet Truong, Thao T.
Dien Bard, Jennifer
Butler-Wu, Susan M.
author_sort Truong, Thao T.
collection PubMed
description Though rapid antigen tests have historically problematic performance characteristics for the diagnosis of respiratory viral infections such as influenza, they have attained an unprecedented level of use in the context of the COVID-19 pandemic. Ease of use and scalability of rapid antigen tests has facilitated a democratization and scale of testing beyond anything reasonably achievable by traditional laboratory-based testing. In this chapter, we discuss the performance characteristics of rapid antigen testing for SARS-CoV-2 detection and their application to non-traditional uses beyond clinical diagnostic testing.
format Online
Article
Text
id pubmed-8894733
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-88947332022-03-04 Rapid Antigen Assays for SARS-CoV-2: Promise and Peril Truong, Thao T. Dien Bard, Jennifer Butler-Wu, Susan M. Clin Lab Med Article Though rapid antigen tests have historically problematic performance characteristics for the diagnosis of respiratory viral infections such as influenza, they have attained an unprecedented level of use in the context of the COVID-19 pandemic. Ease of use and scalability of rapid antigen tests has facilitated a democratization and scale of testing beyond anything reasonably achievable by traditional laboratory-based testing. In this chapter, we discuss the performance characteristics of rapid antigen testing for SARS-CoV-2 detection and their application to non-traditional uses beyond clinical diagnostic testing. Elsevier Inc. 2022-06 2022-03-04 /pmc/articles/PMC8894733/ /pubmed/35636822 http://dx.doi.org/10.1016/j.cll.2022.03.001 Text en © 2022 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Truong, Thao T.
Dien Bard, Jennifer
Butler-Wu, Susan M.
Rapid Antigen Assays for SARS-CoV-2: Promise and Peril
title Rapid Antigen Assays for SARS-CoV-2: Promise and Peril
title_full Rapid Antigen Assays for SARS-CoV-2: Promise and Peril
title_fullStr Rapid Antigen Assays for SARS-CoV-2: Promise and Peril
title_full_unstemmed Rapid Antigen Assays for SARS-CoV-2: Promise and Peril
title_short Rapid Antigen Assays for SARS-CoV-2: Promise and Peril
title_sort rapid antigen assays for sars-cov-2: promise and peril
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8894733/
https://www.ncbi.nlm.nih.gov/pubmed/35636822
http://dx.doi.org/10.1016/j.cll.2022.03.001
work_keys_str_mv AT truongthaot rapidantigenassaysforsarscov2promiseandperil
AT dienbardjennifer rapidantigenassaysforsarscov2promiseandperil
AT butlerwususanm rapidantigenassaysforsarscov2promiseandperil

Ejemplares similares